edgepedia

Life and health

72,234 articles

Immunopathology of schistosomiasis

Immunopathology of schistosomiasis is the study of how disease in schistosome infections arises from the host's immune response to parasite eggs, which drives granulomas and liver fibrosis.

Immunoperoxidase staining

Immunoperoxidase staining is a histology method that detects specific antigens in tissue sections using antibodies linked to horseradish peroxidase, leaving a permanent brown precipitate visible under a light microscope.

ImmunoPET

ImmunoPET is a molecular imaging method in nuclear medicine that pairs radiolabeled monoclonal antibodies with PET to measure where a target accumulates in a patient.

ImmunoPET imaging

ImmunoPET imaging is a molecular imaging method in nuclear medicine that uses radiolabeled monoclonal antibodies and PET to map targets such as HER2 and PD-L1 across all lesions at once, mainly in oncology.

Immunophenotyping

Immunophenotyping is a laboratory assay that identifies and quantifies immune cells by their protein markers, usually via flow cytometry, underpinning leukemia classification, HIV CD4 monitoring, and MRD follow-up.

Immunoprecipitation

Immunoprecipitation (IP), including co-IP, ChIP, and RIP, is an affinity chromatography method that uses a bead-immobilized antibody to purify a target protein or its bound partners from complex mixtures for western blot or mass spectrometry analysis.

Immunoproteasome

Immunoproteasome: an IFN-γ/TNF-α-inducible proteasome variant replacing β1, β2, β5 with β1i/LMP2, β2i/MECL-1, β5i/LMP7, optimized for MHC-I antigen presentation; targeted by selective inhibitors like ONX 0914.

Immunoradiometric assay

An immunoradiometric assay (IRMA) is a non-competitive, sandwich-type immunoassay that quantifies an antigen using antibodies in excess, one labeled with iodine-125, introduced by Miles and Hales in 1968.

Immunoradiotherapy

Immunoradiotherapy is the combination of radiotherapy with immunotherapy, most often checkpoint inhibitors, so radiation turns the tumor into an in-situ vaccine; its clinical anchor is the PACIFIC trial in lung cancer.

Immunoscreening

Immunoscreening is a bench biology method that uses antibodies as probes to identify antigens, or the genes encoding them, within large expression or phage-display libraries.

Immunosequencing

Immunosequencing is a high-throughput sequencing method that enumerates and quantifies T-cell and B-cell receptor clones in a sample, used to track immune responses, monitor minimal residual disease, and profile repertoires in oncology, infection, and vaccination studies.

Immunostaining

Immunostaining is a laboratory method that uses antibodies to bind specific antigens in cells or tissue sections and make their location visible, typically under a microscope.

Immunosuppression

Immunosuppression: reduced ability of the immune system to fight infection and disease, caused by HIV/AIDS, lymphoma, chemotherapy, or radiotherapy, or deliberately induced with drugs such as tacrolimus, cyclosporine, and azathioprine to prevent transplant rejection.

Immunosuppressive drug

Immunosuppressive drugs, also called immunosuppressants, are agents that dampen immune responses to prevent transplant rejection and treat autoimmune disease; major classes include corticosteroids, calcineurin inhibitors, antiproliferatives, mTOR inhibitors, and antibodies.

Immunotactoid glomerulopathy

Immunotactoid glomerulopathy (GOMMID) is a rare kidney disease in which immunoglobulin forms microtubular deposits in the glomeruli, typically causing proteinuria, hematuria, and kidney dysfunction, and is often linked to lymphoma or plasma cell disorders.

Immunotherapy

Immunotherapy, also known as biological therapy, is a treatment that boosts or dampens immune activity to fight cancer, infection, and other diseases; it is a main pillar of cancer care.

Immunotherapy induced hypophysitis

Immunotherapy induced hypophysitis, or ICI-induced hypophysitis, is pituitary inflammation from immune checkpoint inhibitors, mainly ipilimumab (CTLA-4), causing ACTH and TSH deficiency, treated with hormone replacement.

Immunotoxin therapy

Immunotoxin therapy is a cancer treatment fusing a protein toxin to an antibody or ligand that targets tumor cells; three such drugs have been FDA approved since 1999.

Immunoturbidimetry

Immunoturbidimetry is a homogeneous immunoassay technique that quantifies analytes such as serum proteins by measuring the turbidity, or loss of transmitted light, from antigen-antibody complexes, and runs on automated clinical chemistry analyzers.

Imojev md

IMOJEV MD, WHO-prequalified multidose presentation of Imojev (JE-CV, ChimeriVax-JE), a live attenuated chimeric yellow fever 17D/SA14-14-2 Japanese encephalitis vaccine; single 0.5 mL subcutaneous dose, 4-dose vial, made by GPO-MBP Thailand, prequalified 18 September 2014.

Imovax polio

Imovax Polio (IMOVAX POLIO) is Sanofi's inactivated polio vaccine (IPV), licensed in France since 1982 and WHO-prequalified, containing Mahoney, MEF-1, and Saukett strains at 40/8/32 D-antigen units per 0.5 ml dose.

IMP1734 (PARP1-selective inhibitor)

IMP1734 (EIK1003) is a potent, highly selective PARP1 inhibitor developed by IMPACT Therapeutics and licensed to Eikon Therapeutics outside Greater China, in Phase 1/2 trials for advanced solid tumors with HRR mutations.

IMPACNEO trial

IMPACNEO (NCT04735445), a Spanish multicenter pragmatic randomized trial comparing enhanced comprehensive cancer screening with EACS standard care in people with HIV; 4,638 planned participants, 84% adherence, 29.4% positive baseline screening findings.

Impact assessment

Impact assessment: prospective evaluation of the effects of projects, plans, policies, or programs, chiefly on the environment and health. Covers EIA, SEA, HIA, and risk assessment, from NEPA 1969 to Canada's 2019 Impact Assessment Act.

Impact family

The Impact family is a family of eukaryotic proteins named after IMPACT, defined by an N-terminal RWD domain plus a UPF0029 domain; IMPACT, called Yih1 in yeast, binds GCN1 and inhibits the GCN2 kinase.

Impact of the Asian giant hornet on beekeeping and hive defenses

The Asian giant hornet (Vespa mandarinia) can destroy whole honey bee colonies within hours, so beekeepers protect hives with entrance screens and traps instead of relying on the bees' defenses.

IMPACT study (NCT03831490)

IMPACT (NCT03831490), Study for Improving Maternal, Pregnancy and Child Outcomes: Swedish prospective multicentre cohort by Uppsala University, 2018-2022, 13,000 first-trimester pregnancies, building preeclampsia prediction models and a national biobank.

IMPACT trial (NCT07420426)

IMPACT (NCT07420426, IMPACT2025) is a University of Hong Kong randomized trial testing 9 weeks of automated instant message-delivered acceptance and commitment therapy against general mental health messages for neuropsychiatric symptoms in adults aged 50+ with mild cognitive impairment; 160 participants, recruiting, completion expected December 2026.

Impact, N-terminal

Impact, N-terminal (Impact_N) is an InterPro/Pfam protein domain annotation for the IMPACT family of RWD-domain proteins; in human IMPACT (Q9P2X3) it is mapped to residues 182-289, next to a ribosomal protein uS5 domain 2-type region.

Impacted cerumen

Impacted cerumen (earwax blockage, ICD-11 AA42, ICD-10 H61.2): wax accumulation causing symptoms or blocking ear examination; affects 10% of children, 5% of adults; treated with cerumenolytics, irrigation, or manual removal.